Skip to main content
Clinical Trials/CTRI/2018/12/016505
CTRI/2018/12/016505
Not yet recruiting
未知

Registry to Understand Patient characteristics, Treatment Patterns and Therapy Outcomesin Adults with Chronic Hepatitis C Virus Infection

Mylan Laboratories Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B182- Chronic viral hepatitis C
Sponsor
Mylan Laboratories Limited
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients of either sex aged \>\=18 years
  • Patients considered eligible for treatment with DAAs, as per the approved prescribing
  • information
  • Patients willing to provide a completed and signed written consent prior to initiation
  • of treatment

Exclusion Criteria

  • Concurrent participation in a HCV clinical trial (except trials not testing investigational
  • medicinal products)
  • Patient with a risk of uncertainty regarding returning for follow\-up (e.g., patients
  • planning to move or leave the country in a foreseeable future)
  • Pregnant or nursing (lactating) women

Outcomes

Primary Outcomes

Not specified

Similar Trials